United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 2, 2026 · Filed Jul 2, 2026

On Jul 2, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$554.61 for US$5.27M under a trading plan, leaving 40,513 shares. Filed Jul 2, 2026 (Form 4).

Sold
9,500 shares
Price
US$554.61 average (US$548.01 to US$558.37)
Value
US$5.27M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 2, 2026Common StockOption exercise9,500US$135.4250,013Direct
Jul 2, 2026Common StockSale192US$548.0149,821Direct
Jul 2, 2026Common StockSale130US$548.7549,691Direct
Jul 2, 2026Common StockSale118US$549.7749,573Direct
Jul 2, 2026Common StockSale640US$551.5948,933Direct
Jul 2, 2026Common StockSale993US$552.7247,940Direct
Jul 2, 2026Common StockSale776US$553.6447,164Direct
Jul 2, 2026Common StockSale2,006US$554.7545,158Direct
Jul 2, 2026Common StockSale2,942US$555.6742,216Direct
Jul 2, 2026Common StockSale1,343US$556.5640,873Direct
Jul 2, 2026Common StockSale320US$557.6340,553Direct
Jul 2, 2026Common StockSale40US$558.3740,513Direct

Source

View original at SEC

Related